RxDoctor Payments Data

Emily Watson, PA

Physician Assistant · Waynesville, NCNPI 1013312537

Payments from drug & device makers

$326in general payments, 2019–2025

Across 18 payments — averaging $18.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$124
  • GSK$58
  • AbbVie$35
  • Amgen$29
  • Stryker$27
  • Johnson & Johnson$17
  • plus $36 from 3 others

What the payments were for

  • Food & beverage$31596%
  • Education$124%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abbott5$124
GSK4$58
AbbVie2$35
Amgen2$29
Stryker1$27
Johnson & Johnson1$17
Novo Nordisk1$12
Pfizer1$12
Lilly USA, LLC1$12

How this compares

$326 in reported general payments places this provider in the 50th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$41,435
Medicare patients
167
Services billed
572

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide95$138,088
Trelegy ElliptaFluticasone/Umeclidin/Vilanter61$68,915
JardianceEmpagliflozin34$60,214
EliquisApixaban35$48,250
TrulicityDulaglutide25$38,263
MounjaroTirzepatide18$22,610
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr24$18,013
XareltoRivaroxaban11$14,793
Breo ElliptaFluticasone/Vilanterol12$11,709
FarxigaDapagliflozin Propanediol15$10,764
LinzessLinaclotide11$5,596
Lantus SolostarInsulin Glargine,hum.Rec.Anlog27$5,223
Atorvastatin Calcium507$3,857
Albuterol Sulfate HfaAlbuterol Sulfate108$3,316
Omeprazole232$3,013

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$12$138,08895 claims
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta$58$98,63797 claims
Lilly USA, LLCTrulicity, Mounjaro$12$60,87343 claims
PfizerEliquis$12$48,25035 claims
Johnson & JohnsonXarelto$17$14,79311 claims
AbbVieLinzess$35$5,59611 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Waynesville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →